SE437469B - Sett att framstella en farmaceutisk produkt innehallande 4-(2-hydroxi-3-isopropylaminopropoxi)indol(pindolol) - Google Patents

Sett att framstella en farmaceutisk produkt innehallande 4-(2-hydroxi-3-isopropylaminopropoxi)indol(pindolol)

Info

Publication number
SE437469B
SE437469B SE7708265A SE7708265A SE437469B SE 437469 B SE437469 B SE 437469B SE 7708265 A SE7708265 A SE 7708265A SE 7708265 A SE7708265 A SE 7708265A SE 437469 B SE437469 B SE 437469B
Authority
SE
Sweden
Prior art keywords
isopropylaminopropoxy
pindolol
indol
hydroxy
make
Prior art date
Application number
SE7708265A
Other languages
English (en)
Other versions
SE7708265L (sv
Inventor
D Hazler
J A Hersey
J-P Nougaret
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7708265L publication Critical patent/SE7708265L/sv
Publication of SE437469B publication Critical patent/SE437469B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7708265A 1976-07-27 1977-07-18 Sett att framstella en farmaceutisk produkt innehallande 4-(2-hydroxi-3-isopropylaminopropoxi)indol(pindolol) SE437469B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH958876 1976-07-27

Publications (2)

Publication Number Publication Date
SE7708265L SE7708265L (sv) 1978-01-28
SE437469B true SE437469B (sv) 1985-03-04

Family

ID=4353539

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7708265A SE437469B (sv) 1976-07-27 1977-07-18 Sett att framstella en farmaceutisk produkt innehallande 4-(2-hydroxi-3-isopropylaminopropoxi)indol(pindolol)

Country Status (27)

Country Link
JP (1) JPS5315411A (sv)
AR (1) AR216479A1 (sv)
AT (1) AT369987B (sv)
AU (1) AU515738B2 (sv)
BE (1) BE857122A (sv)
CA (1) CA1095833A (sv)
CY (1) CY1261A (sv)
DE (1) DE2732335C2 (sv)
DK (1) DK325677A (sv)
ES (1) ES461020A1 (sv)
FI (1) FI772217A (sv)
FR (1) FR2359607A1 (sv)
GB (1) GB1589982A (sv)
GR (1) GR65014B (sv)
HK (1) HK81884A (sv)
HU (1) HU178340B (sv)
IE (1) IE45534B1 (sv)
IL (1) IL52587A (sv)
KE (1) KE3441A (sv)
MY (1) MY8400057A (sv)
NL (1) NL176227C (sv)
NO (1) NO149874C (sv)
NZ (1) NZ184722A (sv)
PT (1) PT66850B (sv)
SE (1) SE437469B (sv)
SG (1) SG53884G (sv)
ZA (1) ZA774536B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
JPS5748908A (en) * 1980-09-08 1982-03-20 Kyorin Pharmaceut Co Ltd Prolonged release type nicomol pharmaceutical
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS61254522A (ja) * 1985-05-02 1986-11-12 Takada Seiyaku Kk 錠剤組成物
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
GB1301849A (sv) * 1969-12-15 1973-01-04
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions

Also Published As

Publication number Publication date
AU2730177A (en) 1979-02-01
FR2359607B1 (sv) 1980-02-22
FR2359607A1 (fr) 1978-02-24
NO149874B (no) 1984-04-02
NL176227B (nl) 1984-10-16
AT369987B (de) 1983-02-25
DE2732335A1 (de) 1978-02-02
CY1261A (en) 1984-11-23
CA1095833A (en) 1981-02-17
FI772217A (sv) 1978-01-28
MY8400057A (en) 1984-12-31
JPS5315411A (en) 1978-02-13
KE3441A (en) 1984-09-14
JPS5726650B2 (sv) 1982-06-05
HU178340B (en) 1982-04-28
IE45534L (en) 1978-01-27
AR216479A1 (es) 1979-12-28
PT66850B (fr) 1979-03-13
ES461020A1 (es) 1979-05-01
DK325877A (da) 1978-01-20
ATA541377A (de) 1982-07-15
NO149874C (no) 1984-07-11
NL176227C (nl) 1985-03-18
DE2732335C2 (de) 1983-01-20
SG53884G (en) 1985-03-08
BE857122A (fr) 1978-01-25
AU515738B2 (en) 1981-04-30
IE45534B1 (en) 1982-09-22
NZ184722A (en) 1980-10-24
GB1589982A (en) 1981-05-20
IL52587A0 (en) 1977-10-31
SE7708265L (sv) 1978-01-28
DK325677A (da) 1978-01-28
GR65014B (en) 1980-06-13
PT66850A (fr) 1977-08-01
NO772575L (no) 1978-01-30
HK81884A (en) 1984-11-25
ZA774536B (en) 1979-02-28
NL7708162A (nl) 1978-01-31
IL52587A (en) 1980-09-16

Similar Documents

Publication Publication Date Title
SE426152B (sv) Sett att framstella en tverbunden, strengsprutad produkt
SE413237B (sv) Sett att framstella finkornig, amorf, felld kiseldioxid
SE429551B (sv) Sett att framstella 1-(3-dimetylamino-propyl)-ftalanderivat
SE431935B (sv) Sett att framstella drageer
SE7606864L (sv) Sett att framstella syntesgas
SE7711172L (sv) Produkt
SE418473B (sv) Sett att tillverka patronhylsor
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE435928B (sv) Sett att framstella nya 3-aryl-oxazolidin-2-oner
SE7504346L (sv) Sett att framstella en livsmedelsprodukt
SE432727B (sv) Sett att tillverka en form for en gjuten produkt
DK90376A (da) Medicinpakning
SE437469B (sv) Sett att framstella en farmaceutisk produkt innehallande 4-(2-hydroxi-3-isopropylaminopropoxi)indol(pindolol)
IT7919127A0 (it) Recinto pieghevole per bambino.
SE7608799L (sv) Sett att framstella kromanon-(4)
SE432256B (sv) Sett att framstella cellulosaalkyletrar
SE430687B (sv) Sett att framstella hexanitrostilben
FR2327822A1 (fr) Appareil projecteur pulverisateur
SE436037B (sv) Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE7707197L (sv) Vitamin produkt
SE421519B (sv) Sett att framstella parallellepipediska forpackningsbehallare
SE7710042L (sv) Sett att aterupphetta platemnen
SE434397B (sv) Sett att framstella bens-acyl-bensimidazol-2-derivat
FI773812A (fi) Farmaceutiska foereningar